BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 9810330)

  • 1. Quality assurance for 3D conformal radiation therapy.
    Purdy JA; Harms WB
    Strahlenther Onkol; 1998 Oct; 174 Suppl 2():2-7. PubMed ID: 9810330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial experience with quality assurance of multi-institutional 3D radiotherapy clinical trials. A brief report.
    Purdy JA; Harms WB; Michalski J; Bosch WR
    Strahlenther Onkol; 1998 Oct; 174 Suppl 2():40-2. PubMed ID: 9810337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
    Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
    Luo C; Yang CC; Narayan S; Stern RL; Perks J; Goldberg Z; Ryu J; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1253-62. PubMed ID: 17145540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.
    Thomas E; Chapet O; Kessler ML; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):571-8. PubMed ID: 15890602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer.
    Duthoy W; De Gersem W; Vergote K; Boterberg T; Derie C; Smeets P; De Wagter C; De Neve W
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):794-806. PubMed ID: 15465196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance of intensity-modulated radiotherapy.
    Low DA
    Semin Radiat Oncol; 2002 Jul; 12(3):219-28. PubMed ID: 12118387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3D-CRT and intensity modulated radiation therapy (IMRT)].
    Hatano K; Narita Y; Araki H; Sakai M
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2050-5. PubMed ID: 14712764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular PET/CT imaging-guided radiation therapy treatment planning.
    Zaidi H; Vees H; Wissmeyer M
    Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D treatment planning and intensity-modulated radiation therapy.
    Purdy JA
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):155-68. PubMed ID: 10550841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of the detector size effect in 3D-CRT.
    García-Vicente F; Béjar MJ; Pérez L; Torres JJ
    Radiother Oncol; 2005 Mar; 74(3):315-22. PubMed ID: 15763313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dosimetric evaluation for three dimensional conformal, conventional, and traditional radiotherapy plans for patients with early nasopharyngeal carcinoma].
    Luo W; Deng XW; Lu TX
    Ai Zheng; 2004 May; 23(5):605-8. PubMed ID: 15142465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the quality of treatment planning systems in radiation therapy.
    Panten T; Höss A; Bohsung J; Becker G; Sroka-Pérez G
    Strahlenther Onkol; 1998 Oct; 174 Suppl 2():31-5. PubMed ID: 9810335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance of intensity-modulated radiation therapy.
    Palta JR; Liu C; Li JG
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S108-12. PubMed ID: 18406906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing quality assurance processes for image-guided adaptive radiation therapy.
    Yan D
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S28-32. PubMed ID: 18406933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multisegmented tangential breast fields: a rational way to treat breast cancer.
    Gulybán A; Kovács P; Sebestyén Z; Farkas R; Csere T; Karácsonyi G; Dérczy K; Hideghéty K; Esik O
    Strahlenther Onkol; 2008 May; 184(5):262-9. PubMed ID: 18427757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multileaf collimator phantom for the quality assurance of radiation therapy planning systems and CT simulators.
    McNiven A; Kron T; Van Dyk J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):994-1001. PubMed ID: 15465218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.